Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in infertile women with PCOS undergoing IVF
IRCT20240303061157N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapagliflozin in polycystic ovary syndrome (PCOS), sponsored by Zahedan University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20240303061157N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240303061157N1.